Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 487 record(s)

Req # A-2024-000091

Adverse Drug Reaction (ADR) for AVOBENZONE. Report number: 001060287. ADR for . Report number: 001060638. ADRs for HYDROCORTISONE. Report numbers: 001061825, 001063444. ADR for LISTERINE. Report number: 001068710. ADRs for FAMOTIDINE. Report numbers…

Organization: Health Canada

53 page(s)
May 2024

Req # A-2024-000092

Adverse Drug Reaction (ADR). Report number: 001074892.

Organization: Health Canada

2 page(s)
May 2024

Req # A-2024-000110

Adverse Drug Reaction (ADR). Report number: 001075789.

Organization: Health Canada

2 page(s)
May 2024

Req # A-2024-000112

Adverse Drug Reaction (ADR) for Privigen. Report number: 001052985.

Organization: Health Canada

5 page(s)
May 2024

Req # A-2024-000121

Adverse Drug Reaction (ADR) for Privigen. Report number: E2B_001066628.

Organization: Health Canada

3 page(s)
May 2024

Req # A-2024-000156

Adverse Drug Reaction (ADR) for Venofer. Report number: 001078256.

Organization: Health Canada

6 page(s)
May 2024

Req # A-2024-000167

Adverse Drug Reaction (ADR) for Technetium (Tc 99m). Report number: 001075778.

Organization: Health Canada

11 page(s)
May 2024

Req # A-2022-00011

Obtain a complete copy of each of these briefing notes: Briefing Note: CEO Quarterly Meeting with the Alberta Energy Regulator – 26 January 2023 (Ref. # 1447170) Briefing Note: CEO Monthly Meeting with Trans Mountain Corporation – 25 January 2023 (…

Organization: Canada Energy Regulator

9 page(s)
May 2023

Req # A-2023-00001

Requesting the number of Professional Engineers and Geoscientists on the CER staff (or on contract) within the last ten years registered in the Provinces of British Columbia and or Alberta, as members and/or permit-to-practice holders. List to…

Organization: Canada Energy Regulator

0 page(s)
May 2023

Req # A-2015-000351

Application submissions and summary for new drug deferiprone licencing. Common Drug Review minutes kept of review process, Canadian Agency fo Drugs and Technologies in Health's (CADTH) interim and final report. Records from January 1, 2012 to…

Organization: Health Canada

692 page(s)
May 2023
Date modified: